GVOKE KIT
Peakglucagon injection, solution
NDASUBCUTANEOUSSOLUTION
Approved
Sep 2019
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
12.1 Mechanism of Action Glucagon increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver. Hepatic stores of glycogen are necessary for glucagon to produce an antihypoglycemic effect. Extrahepatic…
Pharmacologic Class:
Antihypoglycemic Agent
Loss of Exclusivity
LOE Date
Apr 22, 2036
123 months away
Patent Expiry
Apr 22, 2036